2 completed. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow ZSP1273 600 mg: new trials by email Literature Review of ZSP1273 600 mg trials Research Report on ZSP1273 600 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral) - Influenza A | Phase 3 | Completed | Guangdong Raynovent Biotech Co., Ltd | 750 | 2020-12-28 | 2023-06-27 |
| The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers. ZSP1273 100 mg, Placebo 100 mg, ZSP1273 200 mg - Influenza | Phase 1 | Completed | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 103 | 2018-09-20 | 2019-08-14 |
Influenza, Human (1)
Guangdong Raynovent Biotech Co., Ltd (1) · Guangdong Zhongsheng Pharmaceutical Co., Ltd. (1)
China (2)
Shucheng Hua, MD (1) · Yanhua Ding, MD (1)